| Particulars |
|
|
|
| Company Name
| Dr Reddys Laboratories Ltd
| Year End
| 202403
|
| Full Year |
| Equity (₹ Cr.) |
83.45 |
B.V. (₹) |
322.50 |
| Sales(₹ Cr.) |
19,483.80 |
NP (₹ Cr.) |
4,284.19 |
| NP Var% |
63.00 |
Div% |
800.00 |
| CPS(₹) |
63.00 |
EPS (₹) |
51.30 |
| Traded Value(₹ Lakhs) |
2,295.56 |
52 Week High |
1,420.00 |
| 52 Week Low |
1,076.00 |
Price BSE |
1,110.00 |
| Price NSE |
1,110.00 |
Market Capital (₹ Cr.) |
92,603.68 |
| P/C Ratio |
17.60 |
P/E Ratio |
21.60 |
| Price Vs.BV |
3.44 |
|
| Latest Quarter |
| Year End |
202412 |
Sales (₹ Cr.) |
4,997.80 |
| NP(₹ Cr.) |
849.40 |
NP Var % |
79.00 |
| Trailing Twelve Months |
| Year End |
202412 |
Sales |
21,667.60 |
| OPM |
30.97 |
NP |
4,809.30 |
| NP Var% |
30.25 |
EPS |
62.12 |
| PE |
17.86 |
|
|